04.23.26 -- How To Implement Post-Approval Changes On A Global Level

Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

A robust cleanroom monitoring program is your best defense against contamination. Align your strategy with Annex 1 to detect risks early, protect your product, and ensure patient safety.

Unlock the keys to consistent solid dosage products. Learn to align unique product needs with optimal processing requirements and equipment strategies for improved quality and reproducibility.

Examine the critical role of inspection systems, specifically metal detectors, X-ray systems, and checkweighers, in pharmaceutical manufacturing.

See how incorporating small amounts of mesoporous silica during micronization can significantly enhance powder flow, thereby making subsequent blending and formulation more efficient.

Biopharma–CRO partnerships often struggle with fragmented communication. Gain insight into how streamlined, automated workflows improve transparency, data quality, and operational speed.

Aseptic processing sterilizes products and packaging separately, then combines them in a sterile environment. Find out how this method ensures safety and protects medicines from contamination.

AEX, Low pH, and viral filtration are the most robust mechanisms. Discover how low pH provides the highest overall LRV, while viral filtration is most effective when considering non-enveloped viruses.

Uncover what truly changed in 2025 and how life sciences teams can modernize execution, adopt AI safely, and reduce release cycle friction in 2026, all without compromising compliance.

Partner with an experienced end-to-end CDMO to streamline development, reduce risk, and accelerate your drug’s path to market in today’s complex and competitive pharmaceutical landscape.

The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.

By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

The greatest challenge in drug development can be finding a team capable of carrying a molecule through the complexities. Review three considerations that build a foundation for partnership.

Computer-aided synthesis planning (CASP) can mitigate the impact of rising complexity. Here, we discuss the award-winning AI and vast data that propel a leading predictive retrosynthesis technology.

Learn about a disposable pen that is a proven, globally adopted drug delivery platform with over 175 million units sold, supporting diverse therapies in 40+ countries.